Dihydroisotanshinone I suppresses proliferation and induces the ferroptosis of glioma cells by upregulating the ferroptosis-inducing ACSL4 gene and downregulating the ferroptosis-inhibiting GPX4 gene [74] (Table 1). The gene discussed is GPX4; the disease is central nervous system cancer.